The PJ Pod’s final episode of the year looks ahead to our editorial team’s predictions for pharmacy in 2026. What big changes are coming for the world of pharmacy — and what impact will this have on pharmacists’ day-to-day work?
We also look at the biggest stories of 2025, including a new contract that was deemed the best deal in the past decade, the ten-year health plan and the greater role that pharmacists will play in preventing ill-health within the community, as well as a government consultation on pharmacists combatting medicines shortages by being able to amend prescriptions in limited ways.
Tell us about your own predictions and join our conversation on social media using the hashtag #PJPod, or email us at: editor@pharmaceutical-journal.com.
This episode is presented by Siobhan Chan, senior features editor, and produced by Geoff Marsh.
Thank you to Corrinne Burns, Royal Pharmaceutical Society correspondent; Graham Clews, news editor; Caitlin Killen, clinical editor; Joanna Robertson, senior clinical reporter; and Sophie Willis, investigations editor, for their contributions.
All content for The PJ Pod is the property of Pharmaceutical Journal and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The PJ Pod’s final episode of the year looks ahead to our editorial team’s predictions for pharmacy in 2026. What big changes are coming for the world of pharmacy — and what impact will this have on pharmacists’ day-to-day work?
We also look at the biggest stories of 2025, including a new contract that was deemed the best deal in the past decade, the ten-year health plan and the greater role that pharmacists will play in preventing ill-health within the community, as well as a government consultation on pharmacists combatting medicines shortages by being able to amend prescriptions in limited ways.
Tell us about your own predictions and join our conversation on social media using the hashtag #PJPod, or email us at: editor@pharmaceutical-journal.com.
This episode is presented by Siobhan Chan, senior features editor, and produced by Geoff Marsh.
Thank you to Corrinne Burns, Royal Pharmaceutical Society correspondent; Graham Clews, news editor; Caitlin Killen, clinical editor; Joanna Robertson, senior clinical reporter; and Sophie Willis, investigations editor, for their contributions.
Despite national incentives and locally commissioned services designed to improve availability of palliative care medicines from community pharmacies, access is not evenly distributed across the country.
This problem is only set to get worse with demand for these services expected to increase in the coming decades. Marie Curie has estimated that, if the proportion of people requiring palliative care remains the same, the number of people with palliative care needs in the UK would increase by more than 147,000 between 2023 and 2048 — a rise of 25%.
In this episode of The PJ Pod, executive editor Carolyn Wickware and senior features editor Dawn Connelly discuss what the NHS is doing at local and national levels to ensure patients can maintain their quality of life for as long as possible.
The PJ Pod
The PJ Pod’s final episode of the year looks ahead to our editorial team’s predictions for pharmacy in 2026. What big changes are coming for the world of pharmacy — and what impact will this have on pharmacists’ day-to-day work?
We also look at the biggest stories of 2025, including a new contract that was deemed the best deal in the past decade, the ten-year health plan and the greater role that pharmacists will play in preventing ill-health within the community, as well as a government consultation on pharmacists combatting medicines shortages by being able to amend prescriptions in limited ways.
Tell us about your own predictions and join our conversation on social media using the hashtag #PJPod, or email us at: editor@pharmaceutical-journal.com.
This episode is presented by Siobhan Chan, senior features editor, and produced by Geoff Marsh.
Thank you to Corrinne Burns, Royal Pharmaceutical Society correspondent; Graham Clews, news editor; Caitlin Killen, clinical editor; Joanna Robertson, senior clinical reporter; and Sophie Willis, investigations editor, for their contributions.
